ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Endocrine-Related Cancer 12 (4) 1011 -1016     DOI: 10.1677/erc.1.00996
Copyright © 2005 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montani, M
Right arrow Articles by Perren, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montani, M
Right arrow Articles by Perren, A

No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma

M Montani, A M Schmitt, S Schmid, T Locher, P Saremaslani, P U Heitz, P Komminoth1 and A Perren

Institute for Clinical Pathology, Department of Pathology, University Hospital Zurich, Schmelzbergstr. 12, CH-8091 Zurich, Switzerland
1 Institute for Pathology, Kantonsspital Baden, Baden, Switzerland

(Requests for offprints should be addressed to A Perren; Email: Aurel.Perren{at}usz.ch)

Germline mutations of the three succinate dehydrogenase subunits SDHB, SDHC and SDHD have recently been associated with familial pheochromocytoma and paraganglioma. Several reasons make these genes candidate tumor suppressor genes for medullary thyroid carcinoma (MTC): (1) SDHB lies on chromosome 1p, the region known to be deleted most frequently in MTC, (2) MTCs develop from neural crest-derived cells, as do pheochromocytomas and paragangliomas and (3) patients with germline mutations of the Ret-protooncogene develop MTCs as well as pheochromocytomas, indicating a relationship of these tumors on a genetic level. Therefore, we attempted to determine whether the tumor suppressor genes SDHB, SDHC and SDHD are involved in sporadic and familial MTC. Somatic mutations of the SDH subunits were absent in all 35 investigated MTCs. Loss of heterozygosity was found in 27% (SDHB) and 4% (SDHD) respectively. While the frequency of non-coding, intronic polymorphisms did not differ in MTC patients compared with a control population, an accumulation of amino-acid coding polymorphisms (S163P in SDHB as well as G12S and H50R in SDHD) was found among MTC patients especially patients with familial tumors, suggesting a functional connection of coding SDH polymorphisms to activating Ret mutations.




This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
A. Cerrato, V. De Falco, and M. Santoro
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
J. Mol. Endocrinol., October 1, 2009; 43(4): 143 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
E. Korpershoek, B.-J. Petri, F. H van Nederveen, W. N M Dinjens, A. A Verhofstad, W. W de Herder, S. Schmid, A. Perren, P. Komminoth, and R. R de Krijger
Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma
Endocr. Relat. Cancer, June 1, 2007; 14(2): 453 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
E. Saggiorato, I. Rapa, F. Garino, G. Bussolati, F. Orlandi, M. Papotti, and M. Volante
Absence of RET Gene Point Mutations in Sporadic Thyroid C-Cell Hyperplasia
J. Mol. Diagn., April 1, 2007; 9(2): 214 - 219.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.